Zach Scheiner
Board of Directors at SpyGlass Pharma
San Francisco Bay Area
Overview
Work Experience
Principal
2017 - Current
RA Capital Management is a multi-stage investment manager dedicated to evidence-based investing in public and private healthcare and life science companies that are developing drugs, medical devices, and diagnostics.
Analyst, Equity
2017 - 2017
Associate / Senior Associate
2015 - 2017
RA Capital Management is an investment advisor specializing in the life-sciences and drug development sectors.
Board of Directors
2023
Spyglass Pharma provides medicine for ophthalmic diseases.
Raised $109,782,347.00 from RA Capital Management, Vertex Ventures HC, New Enterprise Associates, Samsara BioCapital and Vensana Capital.
Board of Directors
2021
Board of Directors
2020
Board of Directors
2020
Board of Directors
2017
Board of Directors
2020 - 2023
Adagio Medical is engaged in the research and development of treatments for cardiovascular diseases.
Raised $65,640,111.00 from RA Capital Management, Fjord Ventures, Perceptive Advisors, JMR Capital and ArrowMark Partners.
Science Officer
2011 - 2015
Managed a portfolio of research programs covering a wide range of development stages, therapeutic approaches and scientific fields, concentrated in translational neuroscience.
Science Associate
2009 - 2011
Middle School Science Teacher
1998 - 2001
• Seventh and eighth grade science and math teacher. • High school soccer and tennis coach.